Home/Recalls/FDA-D-0483-2026
FDA DrugsClass II

EPINEPHRINE Injection, USP, 1 mg/10mL (0.1 mg/mL), Rx only, INTERNATIONAL MEDICA...

Published: April 22, 2026Recall ID: D-0483-2026Category: drugsCountry: US

Reason for Recall / Hazard

Lack of Assurance of Sterility

Product Description & Identification

EPINEPHRINE Injection, USP, 1 mg/10mL (0.1 mg/mL), Rx only, INTERNATIONAL MEDICATION SYSTEMS, LIMITED, So. EL Monte, CA 91733, An Amphastar Pharmaceutical Company, NDC 76329-3318-1

Additional Source Details

FieldValue
CitySouth El Monte
StateCA
Openfda › Nui › 1N0000000209
Openfda › Nui › 2N0000000245
Openfda › Nui › 3N0000175552
Openfda › Nui › 4N0000175555
Openfda › Nui › 5N0000175570
Openfda › Nui › 6M0003647
Openfda › UniiYKH834O4BH
Openfda › RouteINTRAVENOUS
Openfda › Rxcui727373
Openfda › Spl idfde15adc-52e9-4f6e-8437-5a450934b280
Openfda › Brand nameEPINEPHRINE
Openfda › Spl set idf2b5f15b-8541-466a-a27a-ee57bc4aac67
Openfda › Package ndc76329-3318-1
Openfda › Product ndc76329-3318
Openfda › Generic nameEPINEPHRINE
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Pharm class csCatecholamines [CS]
Openfda › Substance nameEPINEPHRINE
Openfda › Pharm class epc › 1alpha-Adrenergic Agonist [EPC]
Openfda › Pharm class epc › 2beta-Adrenergic Agonist [EPC]
Openfda › Pharm class epc › 3Catecholamine [EPC]
Openfda › Pharm class moa › 1Adrenergic alpha-Agonists [MoA]
Openfda › Pharm class moa › 2Adrenergic beta-Agonists [MoA]
Openfda › Manufacturer nameInternational Medication Systems, Limited
Openfda › Application numberNDA211363
Openfda › Is original packagertrue
Event id98690
Address 11886 Santa Anita Ave
Address 2N/A
Code infoLot Number: EA038A5, Expiration Date: 08/2026.
Postal code91733-3414
Report date20260422
Product typeDrugs
Product quantity81,520 units
Reason for recallLack of Assurance of Sterility
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260401
Initial firm notificationLetter
Center classification date20260414

Overview

  • Recalling FirmInternational Medication Systems Ltd.
  • StatusOngoing
  • Risk LevelClass II
  • DistributionU.S. Nationwide
Official Agency Alert